Manager News

H.I.G. Capital acquires Canadian biopharma company

The $34 billion private equity powerhouse H.I.G. Capital announced the acquisition of BioVectra in a bid to further expand the Canadian company’s biopharmaceutical business. The BioVectra leadership team has expanded its presence by expanding capacity with the support of in recent years. BioVectra CEO Oliver Technow outlined the company’s growth trajectory that will be supported …

GET THE FULL STORY

Continue reading this article with an annual or monthly subscription. One low price gets you instant access to:

  • All new and archived articles
  • Mandate charts
  • Daily, weekly & monthly newsletters

Start Reading

Tags

Related Articles

Back to top button
Close